<?xml version="1.0" encoding="UTF-8"?>
<ref id="cas14841-bib-0022">
 <label>22</label>
 <mixed-citation publication-type="journal" id="cas14841-cit-0022">
  <string-name>
   <surname>Muro</surname>
   <given-names>K</given-names>
  </string-name>, 
  <string-name>
   <surname>Boku</surname>
   <given-names>N</given-names>
  </string-name>, 
  <string-name>
   <surname>Shimada</surname>
   <given-names>Y</given-names>
  </string-name>, et al. 
  <article-title>Irinotecan plus S‐1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second‐line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non‐inferiority study (FIRIS study)</article-title>. 
  <source xml:lang="en">Lancet Oncol</source>. 
  <year>2010</year>;
  <volume>11</volume>(
  <issue>9</issue>):
  <fpage>853</fpage>‐
  <lpage>860</lpage>.
  <pub-id pub-id-type="pmid">20708966</pub-id>
 </mixed-citation>
</ref>
